Invesco IVZ Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies
Other financials
Where this comes from
Reported directly by Invesco in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.
The official record: Invesco’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Invesco's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Invesco's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
- Invesco (IVZ) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $20.78 in Q1 2026.
- How has Invesco's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value changed year-over-year?
- Invesco's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value increased by 22.2% year-over-year, from $17 to $20.78.
- What is the long-term trend for Invesco's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
- Over 5 years (2020 to 2025), Invesco's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value has grown at a -2.2% compound annual growth rate (CAGR), from $19.11 to $17.12.